From March 17, 2022 to March 31, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on March 19, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.26 CNY | +0.35% | -2.93% | -39.34% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.34% | 3.14B | |
-6.74% | 84.57B | |
+3.95% | 39.93B | |
-26.37% | 27.93B | |
+52.09% | 24.21B | |
-6.59% | 17.17B | |
-32.37% | 13.93B | |
-10.45% | 12.3B | |
-15.88% | 11.84B | |
-2.85% | 7.91B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.